Cochlear Limited Stock Net Income
| OC5 Stock | EUR 118.92 1.08 0.90% |
As of the 18th of February 2026, Cochlear shows the mean deviation of 1.26, and Risk Adjusted Performance of (0.13). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cochlear, as well as the relationship between them. Please confirm Cochlear Limited variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Cochlear Limited is priced correctly, providing market reflects its regular price of 118.92 per share.
Cochlear Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 7.8 B | Enterprise Value Revenue 5.595 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 447.2 M | 259.5 M | |
| Net Income Applicable To Common Shares | 345.7 M | 221.4 M | |
| Net Income | 447.2 M | 259.4 M |
Cochlear | Net Income |
The Net Income trend for Cochlear Limited offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cochlear is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Cochlear's Net Income Growth Pattern
Below is the plot of the Net Income of Cochlear Limited over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cochlear Limited financial statement analysis. It represents the amount of money remaining after all of Cochlear Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cochlear's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cochlear's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 388.9 M | 10 Years Trend |
|
Net Income |
| Timeline |
Cochlear Net Income Regression Statistics
| Arithmetic Mean | 235,878,063 | |
| Coefficient Of Variation | 61.66 | |
| Mean Deviation | 90,374,412 | |
| Median | 245,800,000 | |
| Standard Deviation | 145,449,503 | |
| Sample Variance | 21155.6T | |
| Range | 685.5M | |
| R-Value | 0.42 | |
| Mean Square Error | 18673.7T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | 11,962,305 | |
| Total Sum of Squares | 338488.9T |
Cochlear Net Income History
Cochlear 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cochlear's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cochlear.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Cochlear on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Cochlear Limited or generate 0.0% return on investment in Cochlear over 90 days. Cochlear is related to or competes with Cerence, TELES Informationstech, BIOTIME, MBIA, MBIA, and ANGES MG. Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia P... More
Cochlear Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cochlear's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cochlear Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 19.07 | |||
| Value At Risk | (3.17) | |||
| Potential Upside | 1.82 |
Cochlear Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cochlear's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cochlear's standard deviation. In reality, there are many statistical measures that can use Cochlear historical prices to predict the future Cochlear's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (2.10) |
Cochlear February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (2.09) | |||
| Mean Deviation | 1.26 | |||
| Coefficient Of Variation | (597.31) | |||
| Standard Deviation | 2.35 | |||
| Variance | 5.52 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (2.10) | |||
| Maximum Drawdown | 19.07 | |||
| Value At Risk | (3.17) | |||
| Potential Upside | 1.82 | |||
| Skewness | (4.43) | |||
| Kurtosis | 28.25 |
Cochlear Limited Backtested Returns
Cochlear Limited secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of standard deviation over the last 3 months. Cochlear Limited exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cochlear's mean deviation of 1.26, and Risk Adjusted Performance of (0.13) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cochlear's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cochlear is expected to be smaller as well. At this point, Cochlear Limited has a negative expected return of -0.38%. Please make sure to confirm Cochlear's coefficient of variation, variance, jensen alpha, as well as the relationship between the standard deviation and information ratio , to decide if Cochlear Limited performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Cochlear Limited has weak reverse predictability. Overlapping area represents the amount of predictability between Cochlear time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cochlear Limited price movement. The serial correlation of -0.23 indicates that over 23.0% of current Cochlear price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 13.41 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cochlear Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Cochlear Limited reported net income of 388.9 M. This is 13.95% higher than that of the Health Care Equipment & Supplies sector and 63.33% higher than that of the Health Care industry. The net income for all Germany stocks is 31.89% higher than that of the company.
Cochlear Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cochlear's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cochlear could also be used in its relative valuation, which is a method of valuing Cochlear by comparing valuation metrics of similar companies.Cochlear is currently under evaluation in net income category among its peers.
Cochlear ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cochlear's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cochlear's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Cochlear Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 7.81 B | ||||
| Shares Outstanding | 65.4 M | ||||
| Shares Owned By Insiders | 0.63 % | ||||
| Shares Owned By Institutions | 55.86 % | ||||
| Price To Earning | 43.54 X | ||||
| Price To Book | 7.01 X | ||||
| Price To Sales | 3.33 X | ||||
| Revenue | 2.34 B | ||||
| Gross Profit | 1.7 B | ||||
| EBITDA | 562 M | ||||
| Net Income | 388.9 M | ||||
| Cash And Equivalents | 79.01 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 874.7 M | ||||
| Debt To Equity | 25.20 % | ||||
| Current Ratio | 1.85 X | ||||
| Book Value Per Share | 17.65 X | ||||
| Cash Flow From Operations | 376.5 M | ||||
| Earnings Per Share | 3.15 X | ||||
| Number Of Employees | 5.5 K | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 7.78 B | ||||
| Total Asset | 2.83 B | ||||
| Retained Earnings | 777.3 M | ||||
| Working Capital | 814.5 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 2.37 % | ||||
| Net Asset | 2.83 B | ||||
| Last Dividend Paid | 4.3 |
About Cochlear Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cochlear Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cochlear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cochlear Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Cochlear Stock
Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.